GlassScriptPhysician profile
Timothy Dwight Smith
NPI 1982883344
$149,110.13
in general payments reported to CMS, 2019-2025
18 companies · $4,753 in 2025
The $4,753 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $46K · 2021: $13K · 2022: $34K · 2023: $1,066 · 2024: $15K · 2025: $4,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Consulting Fee: $2,500 · Food and Beverage: $2,181 · Travel and Lodging: $1,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $14,400.00 |
| Consulting Fee | $2,500.00 |
| Food and Beverage | $2,181.16 |
| Travel and Lodging | $1,949.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $134,106.81 | 2019-2025 | Impella |
| Boston Scientific Corporation | $10,879.44 | 2019-2025 | Vitalyst, General - Therapies, Avvigo Guidance System |
| Getinge USA Sales, LLC | $2,326.55 | 2019-2022 | |
| Medtronic, INC. | $440.51 | 2022-2025 | Onyx Frontier, Telescope |
| Abbott Laboratories | $416.86 | 2019-2023 | Absolute Pro |
| Chiesi USA, INC. | $271.87 | 2019-2023 | Kengreal |
| Medtronic Vascular, INC. | $173.03 | 2020 | |
| Cardiovascular Systems INC. | $151.70 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Biotronik INC. | $64.37 | 2022-2023 | Pk Papyrus, Orsiro Mission, Recross |
| Angiodynamics, INC. | $51.09 | 2022-2023 | Alphavac |
| Nuwellis, INC. | $31.67 | 2019 | |
| Cordis US Corp. | $31.08 | 2023 | Mynx Control |
| Cardinal Health 200 LLC | $19.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.36 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $6.72 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.